期刊文献+

妊娠高血压综合征患者血浆VWF和PAI-1水平的变化及临床意义 被引量:3

The changes and clinical significance of plasma von Willebrand factor and plasminogen activator inhibitor type-1 in pregnancy induced hypertension
下载PDF
导出
摘要 目的 :探讨孕妇血浆血管性假血友病因子 (VWF)及纤溶酶原激活物抑制物 1(PAI 1)水平变化与妊高征发病的关系及其临床意义。方法 :应用酶联免疫吸附试验和发色底物法分别检测妊高征组和正常对照组孕妇血浆中VWF和PAI 1水平。结果 :(1)正常妊娠组与轻度妊高征组血浆VWF水平差异无显著性 (P >0 .0 5 ) ,正常妊娠与中、重度妊高征组差异均有显著性 (P <0 .0 5和P <0 .0 1) ;(2 )正常妊娠组血浆PAI 1水平与轻度妊高征比较 ,差异无显著性 (P >0 .0 5 ) ;正常妊娠组与中、重度妊娠组比较差异均有显著性 (P <0 .0 5和P <0 .0 1) ;(3)中、重度妊高征组血浆VWF与PAI 1水平均呈直线正相关关系 (r =0 .70 1,P <0 .0 5 ;r =0 .783,P <0 .0 5 )。结论 :孕妇血浆VWF、PAI 1水平有望成为检测妊高征病情进展的指标 ,VWF、PAI Objective:To study the changes and clinical significance of plasma von Willebrand factor(VWF) and plasminogen activator inhibitor-1(PAI-1) levels in patients with pregnancy induced hypertension(PIH).Methods:The levels of plasma VWF and PAI-1 were detected by ELISA method and chromogenic assay respectively in 69 patients with PIH and 12 normal pregnant women respectively.Results:(1)In mild PIH patients the levels of plasma VWF and PAI-1 were not significantly higher than those in normal group(P>0.05).(2)In moderate PIH patients the parameters significantly increased compared with those in normal group (P<0.05),and so were in severe PIH group(P<0.01).(3)There was a positive correlation between the plasma VWF and PAI-1 level in moderate and severe PIH group(r=0.701,P<0.05;r=0.783,P<0.05 respectively).Conclusions:The levels of plasma VWF and PAI-1 may be two new indexes for the surveillance of PIH.It is important for the diagnosis and therapy of PIH to detect the changes of their levels.
出处 《现代妇产科进展》 CSCD 2003年第3期194-196,共3页 Progress in Obstetrics and Gynecology
关键词 妊娠高血压综合征 纤溶酶原激活物抑制物 血管性假血友病因子 Pregnancy induced hypertension von Willebrand factor Plasminogen activator inhibitor
  • 相关文献

参考文献4

  • 1[1]Jannie DS, Niels .JS, Jesperson J. Perturbed(Procoagulant) endothelial and deviations within the fibrinolytic system duringthe third trimester of nomal pregnancy[J].Acta Obster Gynecol Scand , 1995,74 :257-261
  • 2[2]Blann A D,Tabemer D A.A reliable marker of endothelial celldisfunction :does it exist [J]? Br J Haemotol, 1995,90:244-
  • 3[3]Maki M, Kobayashi K,Terao T,et al .Antithrombin therapy forsevere preeclampsia:results of a double-blind,randomized,placebo-controlled trial[J]. Thombo Haemosta,2000, 84: 583-590
  • 4[4]Koh SC,Anandakumar C,Montan S,et al.Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coaglation in preeclampsia[J]. Gynecol Obstet Invest, 1993,35:214-221

同被引文献16

  • 1易萍,李力.过度性炎症反应与子痫前期[J].现代妇产科进展,2005,14(6):495-497. 被引量:12
  • 2卢国元,郭小芳,王兆钺,白霞,苏健,阮长耿.血管性血友病因子及其裂解酶与系统性红斑狼疮的关系[J].中华内科杂志,2006,45(1):42-44. 被引量:2
  • 3郑媛媛,翟桂荣.子痫前期的凝血功能变化[J].北京医学,2007,29(4):238-240. 被引量:8
  • 4乐杰.妇产科学[M].北京:人民卫生出版社,1998.289.
  • 5[4]Deng L,Bremme K,Hansson LO,et al.Plasma levels of yon Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia[J].Obstet Gynecol,1994,84:914~941.
  • 6Onishi H, Kaniy UK, lwashita M, et al. Fibrin monomer-complex in normal pregnant women:a potential thrombotic marker in pregnancy [J]. Ann Clin Biochem, 2007, 44(4) :449-454.
  • 7Kobusiak-Prokopowicz M ,.lo~da-Myd~owska B ,Zubkiewicz A. Im- pact of nebivolol on levels of serum nitric oxide ,plasma von Wille- brand factor and exercise stress testing parameters in hypertensive and ischemic heart disease patients [J]. Cardiol J,2005,15 (2): 162-168.
  • 8Liu J,Yang J,Sun NL. Association of microalbuminuria and von Willebrand factor with metabolic syndrome in hypertensive patients [J ]. Beijing Da Xue Xue Bao, 2007, 39(6) :587-590.
  • 9Omar SZ,Qvist R,Khaing SL,et al. Thrombophilic mutations in Pre-eclampsia and pregnancy-induced hypertension [J]. Clin Appl Thromb Hemost, 2007,13 (3) : 285-291.
  • 10乐杰.妇产科学[M](第4版)[M].人民卫生出版社,1998.113-115.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部